Casting Oral Cancer Drug Therapy in a Different Light
Casting Oral Cancer Drug Therapy in a Different Light
Lee Schwartzberg, MD, Editor-in-Chief
20090328
2009 Apr 28
Casting Oral Cancer Drug Therapy in a Different Light
2009 Apr 28, Lee Schwartzberg, MD, Editor-in-Chief
Analysis of a recent imatinib study in CML highlights the promise of—and unresolved issues surrounding—oral cancer drugs.
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
